Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

RISING

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 50
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text

PAI HOLDINGS PHARM

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 51
  • 0 comments

FDA approve IBUPROFEN

Comment Full text

NOVAST LABS

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 42
  • 0 comments

FDA approve INDOMETHACIN

Comment Full text

GLAND

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 57
  • 0 comments

FDA approve KETOROLAC TROMETHAMINE

Comment Full text

NOVEL LABS INC

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 55
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text

MACLEODS PHARMS LTD

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 53
  • 0 comments

FDA approve CHOLESTYRAMINE

Comment Full text

ZYDUS PHARMS

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 49
  • 0 comments

FDA approve DIFLUNISAL

Comment Full text

TARO

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 57
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text

DR REDDYS

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 51
  • 0 comments

FDA approve ESOMEPRAZOLE MAGNESIUM; NAPROXEN

Comment Full text

STRIDES PHARMA

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 50
  • 0 comments

FDA approve ASPIRIN; BUTALBITAL; CAFFEINE

Comment Full text
  • Previous
  • 290
  • 291
  • 292
  • 293
  • 294
  • Next

Search

News categories

  • Technical Exchange News(11474)
  • Event(3265)
  • SEC News(213214)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(137009)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin